Daqing Wu to Male
This is a "connection" page, showing publications Daqing Wu has written about Male.
Connection Strength
0.124
-
Li X, Chen Y, Bai L, Zhao R, Wu Y, Xie ZR, Wu JM, Bowen NJ, Danaher A, Cook N, Li D, Qui M, Du Y, Fu H, Osunkoya AO, Kucuk O, Wu D. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. Br J Cancer. 2023 09; 129(5):884-894.
Score: 0.060
-
Li X, Gera L, Zhang S, Chen Y, Lou L, Wilson LM, Xie ZR, Sautto G, Liu D, Danaher A, Mamouni K, Yang Y, Du Y, Fu H, Kucuk O, Osunkoya AO, Zhou J, Wu D. Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer. Theranostics. 2021; 11(14):6873-6890.
Score: 0.051
-
Edwards G, Campbell T, Henderson V, Danaher A, Wu D, Srinivasan R, Rezvani K, Odero-Marah VA. SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth. Biochimie. 2021 Jan; 180:1-9.
Score: 0.012